This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TLGT Teligent (TLGT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Teligent Stock (NASDAQ:TLGT) 30 days 90 days 365 days Advanced Chart Get Teligent alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.01▼$0.0552-Week Range N/AVolume6,460 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ. Read More Receive TLGT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Teligent and its competitors with MarketBeat's FREE daily newsletter. Email Address TLGT Stock News HeadlinesIDT Corp. Cl BApril 23, 2023 | wsj.comLidocaine Market Size is projected to reach USD 3.05 Billion by 2029, growing at a CAGR of 8.45%: Straits Research - Yahoo FinanceJuly 18, 2022 | finance.yahoo.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.August 9 at 2:00 AM | Brownstone Research (Ad)Revlon Case Opens, And LATAM Lands Its Ch. 11 Plan - Law360June 21, 2022 | law360.comTeligent's Post-Sale Drug Recall Puts Its Ch. 11 Plan In Doubt - Law360June 17, 2022 | law360.comTopical Drugs Market Size to Grow by USD 70.95 billion from 2021 to 2026 | Driven by Increase in the Prevalence of Skin Diseases | Technavio - Yahoo FinanceMay 3, 2022 | finance.yahoo.comTeligent Gets Ch. 11 Disclosure, Voting Plans OK'd In Del. - Law360April 27, 2022 | law360.comUS Trustee Calls Teligent Ch. 11 Plan Releases 'Baffling' - Law360April 26, 2022 | law360.comSee More Headlines TLGT Stock Analysis - Frequently Asked Questions How were Teligent's earnings last quarter? Teligent, Inc. (NASDAQ:TLGT) released its quarterly earnings data on Monday, August, 16th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.01. The company had revenue of $10.43 million for the quarter. When did Teligent's stock split? Teligent's stock reverse split on Thursday, May 28th 2020.The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Teligent own? Based on aggregate information from My MarketBeat watchlists, some other companies that Teligent investors own include Meta Platforms (META), Novavax (NVAX), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), TherapeuticsMD (TXMD), AbbVie (ABBV) and Alphabet (GOOG). Company Calendar Last Earnings8/16/2021Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - GENERIC DRG Sub-IndustryN/A Current SymbolNASDAQ:TLGT CIK352998 Webwww.teligent.com Phone(856) 697-1441Fax856-697-1442Employees2,357Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:TLGT) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teligent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teligent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLGT Stock Alerts